The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.
Bauckneht M, Genova C, Rossi G, Rijavec E, Dal Bello MG, Ferrarazzo G, Tagliamento M, Donegani MI, Biello F, Chiola S, Zullo L, Raffa S, Lanfranchi F, Cittadini G, Marini C, Lopci E, Sambuceti G, Grossi F, Morbelli S.
Bauckneht M, et al. Among authors: lopci e.
Cancers (Basel). 2021 Jun 22;13(13):3117. doi: 10.3390/cancers13133117.
Cancers (Basel). 2021.
PMID: 34206545
Free PMC article.